McHorney CA - Search Results

1

Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure.

McHorney CA, Crivera C, Laliberté F, Nelson WW, Germain G, Bookhart B, Martin S, Schein J, Lefebvre P, Deitelzweig S. McHorney CA, et al. Curr Med Res Opin. 2015 Dec;31(12):2167-73. doi: 10.1185/03007995.2015.1096242. Epub 2015 Oct 22. Curr Med Res Opin. 2015. PMID: 26393483

2

Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation.

McHorney CA, Peterson ED, Laliberté F, Germain G, Nelson WW, Crivera C, Schein J, Lefebvre P. McHorney CA, et al. Clin Ther. 2016 Nov;38(11):2477-2488. doi: 10.1016/j.clinthera.2016.09.014. Epub 2016 Oct 24. Clin Ther. 2016. PMID: 27789043

3

Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation.

McHorney CA, Ashton V, Laliberté F, Germain G, Wynant W, Crivera C, Schein JR, Lefebvre P, Peterson ED. McHorney CA, et al. J Manag Care Spec Pharm. 2017 Sep;23(9):980-988. doi: 10.18553/jmcp.2017.23.9.980. J Manag Care Spec Pharm. 2017. PMID: 28854075 Free PMC article.

4

Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.

McHorney CA, Crivera C, Laliberté F, Germain G, Wynant W, Lefebvre P. McHorney CA, et al. PLoS One. 2018 Apr 5;13(4):e0194099. doi: 10.1371/journal.pone.0194099. eCollection 2018. PLoS One. 2018. PMID: 29621248 Free PMC article.

5

Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients.

McHorney CA, Peterson ED, Ashton V, Laliberté F, Crivera C, Germain G, Sheikh N, Schein J, Lefebvre P. McHorney CA, et al. Curr Med Res Opin. 2019 Apr;35(4):653-660. doi: 10.1080/03007995.2018.1530205. Epub 2018 Oct 30. Curr Med Res Opin. 2019. PMID: 30265159

6

Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis.

Weeda ER, Coleman CI, McHorney CA, Crivera C, Schein JR, Sobieraj DM. Weeda ER, et al. Among authors: mchorney ca. Int J Cardiol. 2016 Aug 1;216:104-9. doi: 10.1016/j.ijcard.2016.04.082. Epub 2016 May 1. Int J Cardiol. 2016. PMID: 27144286

7

The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.

McHorney CA, Schousboe JT, Cline RR, Weiss TW. McHorney CA, et al. Curr Med Res Opin. 2007 Dec;23(12):3137-52. doi: 10.1185/030079907X242890. Curr Med Res Opin. 2007. PMID: 17988435

8

Persistence across weekly and monthly bisphosphonates: analysis of US retail pharmacy prescription refills.

Weiss TW, Henderson SC, McHorney CA, Cramer JA. Weiss TW, et al. Among authors: mchorney ca. Curr Med Res Opin. 2007 Sep;23(9):2193-203. doi: 10.1185/030079907X226069. Curr Med Res Opin. 2007. PMID: 17686228

9

The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease.

McHorney CA. McHorney CA. Curr Med Res Opin. 2009 Jan;25(1):215-38. doi: 10.1185/03007990802619425. Curr Med Res Opin. 2009. PMID: 19210154

10

An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study.

Weiss TW, Gold DT, Silverman SL, McHorney CA. Weiss TW, et al. Among authors: mchorney ca. Curr Med Res Opin. 2006 May;22(5):949-60. doi: 10.1185/030079906X104740. Curr Med Res Opin. 2006. PMID: 16709316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page